Pfizer's Covid Drug Paxlovid May Reduce the Risk of Developing Long Covid, Study Says
People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.
The Latest
-
If You Had Covid Before You Were Vaccinated, You Might Have Less Immunity Than You Think, Study Says
The study, led by Stanford University researchers, challenges prior studies that suggest a Covid infection enhances a vaccinated individual’s immune response.
-
Biden Signs Legislation to Declassify Certain Intelligence on Covid Pandemic Origins
Biden signed legislation requiring the declassification of information on any possible links between a lab in China and the origins of the Covid-19 pandemic.
-
New COVID Origins Data Suggest Pandemic Linked to Raccoon Dogs at Wuhan Market
Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, suggesting the pandemic may have originated from animals, not a lab, international experts say.
-
Study Calls COVID's Mental Health Impact ‘Minimal.' The Responses Perfectly Capture 2020
‘It’s a way to speak back to the idea that all harm is measurable,’ according to a psychologist.
-
FDA Staff Report Says Data Shows Pfizer's Covid Treatment Paxlovid Is Effective in High-Risk Adults
FDA staff said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.
-
Pandemic 3 Years Later: Has the COVID-19 Virus Won?
It’s been three years since the World Health Organization’s first called COVID-19 a pandemic on March 11, 2020. The anniversary on Saturday has health experts taking stock of successes and failures. The coronavirus has killed nearly 7 million worldwide and appears here to stay. It spreads easily from person to person, riding respiratory dropl... -
House Votes to Declassify Info About Origins of COVID-19
The House has voted unanimously to declassify U.S. intelligence information about the origins of COVID-19. The 419-0 vote Friday was a sweeping show of bipartisan support near the third anniversary of the start of the deadly pandemic. It was final approval of the bill, sending it to President Joe Biden’s desk to be signed into law. Debate was brief... -
Couple Left on Island of Dominica When Man, 78, Gets COVID on Caribbean Cruise
A D.C. man is trying to assist his 80-year-old mother from almost 2,000 miles away after she got removed from a Caribbean cruise when her boyfriend came down with COVID-19.
-
Biden Proposes $1.6 Billion to Crack Down on COVID Relief Fraud
President Joe Biden’s administration is asking Congress to agree to pay more than $1.6 billion to help clean up the mess of fraud against the massive government coronavirus pandemic relief programs.
-
FBI Director Accuses China of Trying to ‘Thwart and Obfuscate' Covid Origin Probe
FBI Director Chris Wray said the FBI believes Covid probably originated from a “potential lab incident” in Wuhan.
-
US Energy Department Assesses With ‘Low Confidence' COVID-19 May Have Originated From Chinese Lab Leak
The intelligence community is still in disagreement about the origins of Covid.
-
FDA Authorizes First Combination Flu-COVID Test for Home Use
The Food and Drug Administration on Friday approved the first combination test for flu and COVID-19 that can be used at home, giving consumers an easy way to determine if a runny nose is caused by either disease.
-
‘Died Suddenly' Online Campaign is Twisting Tragedies to Push Vaccine Lies
A growing online conspiracy theory is using the tagline “died suddenly” to baselessly claim that COVID-19 vaccines are killing people.
-
U.S. Plans to Stop Buying Covid Shots for the Public This Fall. Here's What That Means for You
Under the Affordable Care Act, most Americans would still get their Covid shots for free once the vaccine program goes commercial.
